Latest Origami Therapeutics News & Updates
See the latest news and media coverage for Origami Therapeutics. We track all announcements, press releases, and industry mentions in real time, all in one place.
Developer of protein degradation therapeutics
origamitherapeutics.com- Headquarters
- San Diego, United States
- Founded year
- 2016
- Company type
- Private company
- Number of employees
- 5–10
Last updated
Latest news about Origami Therapeutics
Company announcements
-
Origami Therapeutics enters global collaboration with Ipsen
They advance a small-molecule protein degrader for a rare neurodegenerative disorder using ORICISION™ technology.
-
Origami Therapeutics announces global collaboration with Ipsen
Ipsen obtains exclusive option to license Origami's protein degrader program for a rare neurodegenerative disorder. Ipsen would handle global development upon exercising the option.
-
Origami Therapeutics wins BioChallenge prize
The company is named a prize winner at the New Orleans BioInnovation Center 2024 BioChallenge. It feels proud and inspired to strive for patients.
-
Origami Therapeutics joins Y Combinator
Announced on February 8, 2024. Links to information about Y Combinator funded companies.
Media coverage
-
Origami Therapeutics Announces Global Collaboration with Ipsen to Advance Protein Degrader Program
Origami Therapeutics, a biotech company developing small molecule protein degraders and conformation correctors to treat neurodegenerative diseases, today announced a global collaboration and option agreement...
Track Origami Therapeutics and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Origami Therapeutics competitors & trending companies
Browse news for competitors to Origami Therapeutics and other trending companies.
Acelot
Dunad Therapeutics
Pit
Davis AI
Qutwo
DigiPowerX
Penguin Solutions
Sterling Infrastructure
KIOXIA Corporation
Subquadratic
Tibber
IREN
A24
Hitachi Energy
Ouster
Ormat Technologies
Fabrinet
AOI
WidePoint
Filtronic
Mirum Pharmaceuticals
Capstone Green Energy
AXT
POET Technologies
PurpleFire
Profitable Media
Sironax
Aperture Therapeutics
Attentive
Klaviyo
Twilio
Insider One
Zeta Global
Iterable
Braze